Buprenorphine vs Nivolumab

Buprenorphine vs Nivolumab: Overview

This comparison examines the pharmacological differences between Buprenorphine and Nivolumab.

Mechanism of Action

Buprenorphine: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Buprenorphine — 24-42 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Buprenorphine — C29H41NO4.

Molecular Weight: Buprenorphine — 467.6430 g/mol.

Type: Buprenorphine — Small molecule; Nivolumab — Antibody.